EligibleTrials

Cross-over Study of Coronary Risk Factors With a Polypill

Recruiting · NCT05030818 · Interventional (participants receive a specific treatment) · Lead sponsor: Fundación EPIC

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

Drugs taken separately: acetylsalicylic acid, ramipril and atorvastatinPolypill of acetylsalicylic acid, ramipril and atorvastatin

What this trial is about

Open-label, randomized, cross-over study conducted in a single center, applied to patients receiving a polypill with 100 mg of acetyl salicylic acid and different doses of ramipril and atorvastatin for indication of secondary prevention according to clinical practice, with objective of analyzing the level of systolic blood pressure and LDL-cholesterol in the same patient in 2 different periods: one under treatment of 3 months with the polypill and another of 3 months with the components separately.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.